News

Frontage Shanghai announced the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. ("Heyan Biotech") Heyan Biotech, located in Wuhan Optics Valley,…
Read More...

Virios Therapeutics, Inc. a clinical-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, announced that the…
Read More...

Recro Pharma, Inc. a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges in small molecule therapeutic…
Read More...

National Resilience, Inc. (Resilience), a company seeking to build the world’s most advanced biopharmaceutical manufacturing ecosystem, and Moderna, Inc. a biotechnology company…
Read More...

Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc. a biopharmaceutical company that discovers, develops, and markets transformative therapies for disease…
Read More...

Takeda Pharmaceutical Company Limited announced that the Government of Japan’s Ministry of Health, Labour and Welfare (MHLW) will purchase 150 million doses of Novavax’ vaccine…
Read More...

INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning, announced it has successfully…
Read More...

Telix is pleased to announce it has commenced a collaboration with Kettering Health, a faith-based network of 13 hospitals, emergency centers, and outpatient facilities located in…
Read More...

Adaptimmune Therapeutics plc a leader in cell therapy to treat cancer, announced today that it has entered into a strategic collaboration and license agreement with Genentech, a member…
Read More...

EnGeneIC Limited, an Australian, Sydney-based biotechnology company, has developed a globally unique nanocellular technology that in pre-clinical animal studies has been shown to…
Read More...

NeuExcell Therapeutics and Spark Therapeutics, a member of the Roche Group announced a gene therapy collaboration aimed at developing a safe and effective treatment for patients…
Read More...

JW Therapeutics an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, announced that the National Medical Products…
Read More...

GeneQuantum Healthcare (Suzhou) Co.,Ltd. and BrighGene Biomedical (Suzhou) Co.,Ltd. signed a co-development agreement for antibody immune agonist conjugate (AIAC), GQ1007. GQ1007 is…
Read More...

AstraZeneca and the European Commission have reached an agreement that ends legal proceedings over the execution of the Advance Purchase Agreement for the delivery of the COVID-19…
Read More...

Ultomiris (ravulizumab) has been approved in the European Union for expanded use to include children (with a body weight of 10 kg or above) and adolescents with paroxysmal nocturnal…
Read More...

Sorrento Therapeutics, Inc. announced the start of enrollment in its Phase 2 efficacy study of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC) for patients suffering…
Read More...

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced it has completed the transaction to acquire LakePharma Inc., a privately held…
Read More...

Agilent Technologies Inc. announced the signing of a worldwide distribution agreement with Visiopharm, enabling Agilent to co-market Visiopharm’s portfolio of CE-IVD marked artificial…
Read More...

Entos Pharmaceuticals (Entos), a clinical-stage biotechnology company developing genetic medicines with its Fusogenix proteolipid vehicle (PLV) nucleic acid delivery platform, is…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced it has initiated its submission to the U.S. Food and Drug Administration (FDA)…
Read More...